Company intelligence / Profile preview

BiotaX Labs

Ramat Gan, Tel Aviv District, Israelbiotax.co ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

BiotaX is developing explainable AI models and cloud-based metagenomics platforms to analyze the human microbiome for disease diagnosis and personalized live biotherapeutic interventions. The company is focused on early cancer detection and prevention using advanced machine learning applied to biological data. No published clinical results are available as of now.

Therapeutic areas: OncologyOther
Modalities: Live biotherapeutic product therapyDiagnostic platformMicrobial therapyGenomic informatics solutions
Industry: Biotech

Partnerships

Illumina Accelerator portfolio companycollaboration with Technion Research & Development Foundation

Beyond the preview

Go deeper on BiotaX Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BiotaX Labs.

Explore the full profile